fenofibrate has been researched along with danazol in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (9.52) | 29.6817 |
| 2010's | 19 (90.48) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Aleo, MD; Bonin, PD; Luo, Y; Potter, DM; Swiss, R; Will, Y | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Fatouros, DG; Jacobsen, F; Kleberg, K; Müllertz, A | 1 |
| Annaert, P; Augustijns, P; Bevernage, J; Brouwers, J; Forier, T; Tack, J | 1 |
| Collnot, EM; Djuric, D; Fabian, E; Hempel, K; Kolter, K; Lehr, CM; Linn, M | 1 |
| Devraj, R; Mullertz, A; Porter, CJ; Pouton, CW; Warren, DB; Williams, HD | 1 |
| Porter, CJ; Trevaskis, NL; Yeap, YY | 1 |
| Devraj, R; Porter, CJ; Pouton, CW; Warren, DB; Williams, HD | 1 |
| Decker, H; Hellmann, N; Johnson, R; Khoshakhlagh, P; Langguth, P; Nawroth, T; Schmueser, L; Szekely, NK | 1 |
| Jensen, MK; Michaelsen, MH; Mosgaard, MD; Mu, H; Müllertz, A; Rades, T; Sassene, PJ; Van Den Broek, E; Wasan, KM | 1 |
| Denkov, ND; Katev, V; Radeva, D; Tcholakova, S; Vinarov, Z | 1 |
| Burdzhiev, N; Denkov, N; Katev, V; Tcholakova, S; Vinarov, Z | 1 |
| Bergström, CAS; Keemink, J; Mårtensson, E | 1 |
1 review(s) available for fenofibrate and danazol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
20 other study(ies) available for fenofibrate and danazol
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Human drug-induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pump.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Chemical and Drug Induced Liver Injury; Humans; Male; Mitochondria, Liver; Rats; Rats, Sprague-Dawley; Severity of Illness Index | 2014 |
Biorelevant media simulating fed state intestinal fluids: colloid phase characterization and impact on solubilization capacity.
Topics: Algorithms; Bile; Body Fluids; Chromatography, High Pressure Liquid; Cinnarizine; Colloids; Danazol; Emulsions; Fatty Acids, Nonesterified; Fenofibrate; Intestinal Mucosa; Light; Micelles; Microscopy, Electron, Transmission; Monoglycerides; Particle Size; Scattering, Radiation; Solubility; Solutions; Surface Tension | 2010 |
Excipient-mediated supersaturation stabilization in human intestinal fluids.
Topics: Acetamides; Acetophenones; Adult; Body Fluids; Danazol; Excipients; Female; Fenofibrate; Humans; Intestines; Male; Nitriles; Pharmaceutical Preparations; Polymers; Pyridazines; Pyrimidines; Ritonavir; Solubility; Young Adult | 2011 |
Soluplus® as an effective absorption enhancer of poorly soluble drugs in vitro and in vivo.
Topics: Administration, Oral; Animals; Area Under Curve; Biological Availability; Biological Transport; Caco-2 Cells; Danazol; Dogs; Excipients; Female; Fenofibrate; Humans; Intestinal Absorption; Itraconazole; Pharmaceutical Preparations; Polyethylene Glycols; Polyvinyls; Solubility | 2012 |
In vitro digestion testing of lipid-based delivery systems: calcium ions combine with fatty acids liberated from triglyceride rich lipid solutions to form soaps and reduce the solubilization capacity of colloidal digestion products.
Topics: Bile Acids and Salts; Calcium; Chemical Precipitation; Colloids; Danazol; Digestion; Drug Delivery Systems; Fatty Acids; Fenofibrate; Lipids; Solubility; Soybean Oil; Triglycerides | 2013 |
The potential for drug supersaturation during intestinal processing of lipid-based formulations may be enhanced for basic drugs.
Topics: Animals; Chemistry, Pharmaceutical; Cinnarizine; Colloids; Danazol; Fenofibrate; Intestinal Mucosa; Kinetics; Male; Models, Theoretical; Phenanthrenes; Rats; Rats, Sprague-Dawley; Solubility | 2013 |
Choice of nonionic surfactant used to formulate type IIIA self-emulsifying drug delivery systems and the physicochemical properties of the drug have a pronounced influence on the degree of drug supersaturation that develops during in vitro digestion.
Topics: Chemical Precipitation; Colloids; Danazol; Drug Carriers; Drug Delivery Systems; Emulsions; Estrogen Antagonists; Fenofibrate; Hypolipidemic Agents; Lipids; Solubility; Surface-Active Agents | 2014 |
Fasted-state simulated intestinal fluid "FaSSIF-C", a cholesterol containing intestinal model medium for in vitro drug delivery development.
Topics: Body Fluids; Caco-2 Cells; Carbamazepine; Cholesterol; Danazol; Drug Delivery Systems; Fasting; Female; Fenofibrate; Griseofulvin; Humans; Intestinal Absorption; Intestinal Mucosa; Male; Models, Theoretical; Particle Size; Solubility | 2015 |
In Vivo Precipitation of Poorly Soluble Drugs from Lipid-Based Drug Delivery Systems.
Topics: Acetaminophen; Animals; Danazol; Drug Carriers; Drug Delivery Systems; Fenofibrate; Gastric Emptying; Lipids; Lipolysis; Male; Microscopy, Polarization; Rats; Rats, Sprague-Dawley; Solubility; X-Ray Diffraction | 2016 |
Micellar solubilization of poorly water-soluble drugs: effect of surfactant and solubilizate molecular structure.
Topics: Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Danazol; Ethylene Oxide; Excipients; Fenofibrate; Micelles; Molecular Structure; Pharmaceutical Preparations; Sodium Dodecyl Sulfate; Solubility; Solvents; Spectrophotometry, Ultraviolet; Steroids; Surface-Active Agents | 2018 |
Effect of Surfactant-Bile Interactions on the Solubility of Hydrophobic Drugs in Biorelevant Dissolution Media.
Topics: Administration, Oral; Animals; Chemistry, Pharmaceutical; Danazol; Drug Liberation; Fenofibrate; Hydrophobic and Hydrophilic Interactions; Intestinal Absorption; Micelles; Progesterone; Proton Magnetic Resonance Spectroscopy; Solubility; Surface-Active Agents; Swine; Taurodeoxycholic Acid; Water | 2018 |
Lipolysis-Permeation Setup for Simultaneous Study of Digestion and Absorption in Vitro.
Topics: Absorption, Physicochemical; Administration, Oral; Caco-2 Cells; Chemistry, Pharmaceutical; Danazol; Digestion; Drug Compounding; Fenofibrate; Humans; In Vitro Techniques; Intestinal Absorption; Lipase; Lipids; Lipolysis; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Solubility | 2019 |